Author

Zakaria El Harrak

Observed name: Z. El Harrak

Observed institutions: Centre National de la Recherche Scientifique, Inserm, La Ligue Contre le Cancer, Université Paris Descartes, Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique

OpenAlex ID: A5074239278

Clinical Relevance of KRAS -Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy

2014 · Pierre Laurent-Puig, Deniz Pekin, et al. · Clinical Cancer Research · 166

High throughput single cell counting in droplet-based microfluidics

2017 · Heng Lu, Ouriel Caen, et al. · Scientific Reports · 66

Abstract 5235: Circulating tumor DNA as a prognostic marker in colorectal cancer: Preliminary results of a prospective trial

2015 · Pierre Laurent-Puig, Olivier Bouché, et al. · Cancer Research · 4

Author Correction: High throughput single cell counting in droplet-based microfluidics

2020 · Heng Lu, Ouriel Caen, et al. · Scientific Reports · 1

Abstract 4211: Detection and quantification of minoritary subclones of KRAS in metastatic colorectal cancers by digital microfluidics: therapeutic implications.

2013 · Deniz Pekin, Corinne Normand, et al. · Cancer Research · 1

Data from Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy

2023 · Pierre Laurent-Puig, Deniz Pekin, et al.

Supplemental Materials from Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy

2023 · Pierre Laurent-Puig, Deniz Pekin, et al.

Detection and Quantification of Minority Kras Subclones in Tumors Using Droplet-based Microfluidics: Clinical Implication

2013 · Deniz Pekin, C. Normand, et al.

Works count: 8

Citation count: 238

H-index: 3

I10-index: 2